Skip to main content

Advertisement

SpringerLink
Log in

Skin Fungal Infections in Children: Diagnostic Challenges

  • Pediatric Fungal Infections (D Corzo Leon, Section Editor)
  • Published:
Current Fungal Infection Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Children are usually affected by superficial mycoses; however, subcutaneous mycoses are rarer and difficult to diagnose since their presentation, risk factors, epidemiology, and probably pathophysiology sometimes differ from adults. This article provides an updated overview of skin fungal infections affecting children, their clinical manifestations, and practical approaches for a correct diagnosis and management.

Recent Findings

Skin fungal infections in children have increased in number in the last decades. The majority of children suffer from one at least one time during infancy. This is probably the result of changing lifestyles, and immunosuppression (such as HIV, transplants, neoplastic diseases, and iatrogenic immunosuppression).

Summary

Children can suffer from a superficial fungal infection (skin, nails, and hair), which usually is easily diagnosed and amenable to treatment; but subcutaneous fungal infections may cause difficulties in diagnosis and treatment. The incidence rate is increasing at an alarming rate and available treatments should be chosen carefully in order to avoid future resistance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Hay RJ. Fungal infections. Clin Dermatol. 2006;24(3):201–12. https://doi.org/10.1016/j.clindermatol.2005.11.011.

    Article  PubMed  Google Scholar 

  2. Arenas R, Moreno-Coutiño G, Welsh O. Classification of subcutaneous and systemic mycoses. Clin Dermatol. 2012;30(4):369–71. https://doi.org/10.1016/j.clindermatol.2011.09.006.

    Article  PubMed  Google Scholar 

  3. Jain A, Jain S, Rawat S. Emerging fungal infections among children: a review on its clinical manifestations, diagnosis and prevention. J Pharm Bioallied Sci. 2010 Oct;2(4):314–20. https://doi.org/10.4103/0975-7406.72131.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Walsh TJ, Dixon DM. Spectrum of mycoses. In: Baron S, editor. Medical microbiology. 4th ed. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 75. Available from: https://www.ncbi.nlm.nih.gov/books/NBK7902/.

  5. •• Taudorf E, Jemec G, Hay R, Saunte D. Cutaneous candidiasis – an evidence-based review of topical and systemic treatments to inform clinical practice. J Eur Acad Dermatol Venereol. 2019;33(10):1863–73. https://doi.org/10.1111/jdv.15782(This article features an extensive review of available treatments for candidiasis, their effectiveness, comparisons between them, and adverse effects).

    Article  CAS  PubMed  Google Scholar 

  6. Bhai N, Tendolkar U, Baradkar V, Mathur M, Kulkarni M. Paediatric oropharyngeal and cutaneous candidiasis with special reference to Candida dubliniensis. J Med Microbiol. 2014;63(4):518–21. https://doi.org/10.1099/jmm.0.060236-0.

    Article  PubMed  Google Scholar 

  7. Bonifaz, et al. Superficial mycoses associated with diaper dermatitis. Mycopathologia. 2016;181(9–10):671–9. https://doi.org/10.1007/s11046-016-0020-9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Moyes DL, Wilson D, Richardson JP, Mogavero S, Tang SX, Wernecke J, et al. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature. 2016;532(7597):64–8. https://doi.org/10.1038/nature17625.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Naglik JR, Gaffen SL, Hube B. Candidalysin: discovery and function in Candida albicans infections. Curr Opin Microbiol. 2019;52:100–9. https://doi.org/10.1016/j.mib.2019.06.002.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ho J, Yang X, Nikou SA, Kichik N, Donkin A, Ponde NO, et al. Candidalysin activates innate epithelial immune responses via epidermal growth factor receptor. Nat Commun. 2019;10(1):2297. https://doi.org/10.1038/s41467-019-09915-2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Swidergall M, Khalaji M, Solis NV, Moyes DL, Drummond RA, Hube B, et al. Candidalysin is required for neutrophil recruitment and virulence during systemic Candida albicans infection. J Infect Dis. 2019;220(9):1477–88. https://doi.org/10.1093/infdis/jiz322.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. King J, Pana ZD, Lehrnbecher T, Steinbach WJ, Warris A. Recognition and clinical presentation of invasive fungal disease in neonates and children. J Pediatric Infect Dis Soc. 2017;6(suppl_1):S12–21. https://doi.org/10.1093/jpids/pix053.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Smolinski KN, Shah SS, Honig PJ, Yan AC. Neonatal cutaneous fungal infections. Curr Opin Pediatr. 2005;17(4):486–93. https://doi.org/10.1097/01.mop.0000171320.91677.55.

    Article  PubMed  Google Scholar 

  14. •• Kaufman DA, Coggins SA, Zanelli SA, Weitkamp JH. Congenital cutaneous candidiasis: prompt systemic treatment is associated with improved outcomes in neonates. Clin Infect Dis. 2017;64(10):1387–95. https://doi.org/10.1093/cid/cix119(A complete description of the clinical picture, risk factors, evolution, and recommendations about treatment for congenital cutaneous candidiasis are detailed).

    Article  PubMed  Google Scholar 

  15. Rex, et al. Practice guidelines for the treatment of candidiasis. Clin Infect Dis. 2000;30(4):662–78. https://doi.org/10.1086/313749.

    Article  CAS  PubMed  Google Scholar 

  16. Marty M, Bourrat E, Vaysse F, Bonner M, Bailleul-Forestier I. Direct microscopy: a useful tool to diagnose oral candidiasis in children and adolescents. Mycopathologia. 2015;180(5–6):373–7. https://doi.org/10.1007/s11046-015-9933-y.

    Article  PubMed  Google Scholar 

  17. Arenas R, Torres E. Candidosis (candidiasis). In: Serrano H, editor. Micología médica ilustrada. 6th ed. México: McGraw-Hill; 2019. p. 249–69.

    Google Scholar 

  18. Sanghvi R, Siddik D, Hullah E, Shah T, Carey B. Chronic mucocutaneous candidiasis: a rare diagnosis in paediatric dentistry. Br J Oral Maxillofac Surg. 2020;58:708–10. https://doi.org/10.1016/j.bjoms.2020.03.025.

    Article  CAS  PubMed  Google Scholar 

  19. Green L, Dolen WK. Chronic candidiasis in children. Curr Allergy Asthma Rep. 2017;17(5):31. https://doi.org/10.1007/s11882-017-0699-9.

    Article  CAS  PubMed  Google Scholar 

  20. •• Matsubara VH, Bandara HM, Mayer MP, Samaranayake LP. Probiotics as antifungals in mucosal candidiasis. Clin Infect Dis. 2016;62(9):1143–53. https://doi.org/10.1093/cid/ciw038(The evidence of the benefits of using probiotics in candidiasic infections and general health with in vivo or in vitro studies is detailed).

    Article  PubMed  Google Scholar 

  21. Admani S, Jinna S, Friedlander S, Sloan B. Cutaneous infectious diseases: kids are not just little people. Clin Dermatol. 2015;33:657–71. https://doi.org/10.1016/j.clindermatol.2015.09.008.

    Article  PubMed  Google Scholar 

  22. Zampella JG, Kwatra SG, Blanck J, Cohen B. Tinea in tots: cases and literature review of oral antifungal treatment of tinea capitis in children under 2 years of age. J Pediatr. 2017;183:12–18.e3. https://doi.org/10.1016/j.jpeds.2016.12.042.

    Article  PubMed  Google Scholar 

  23. Fremerey C, Nenoff P. Tinea capitis in a newborn. N Engl J Med. 2018;378(21):2022. https://doi.org/10.1056/NEJMicm1711862.

    Article  PubMed  Google Scholar 

  24. Moriarty B, Hay R, Morris-Jones R. The diagnosis and management of tinea. BMJ. 2012;345:e4380. https://doi.org/10.1136/bmj.e4380.

    Article  PubMed  Google Scholar 

  25. Rebollo N, López-Barcenas A, Arenas R. Tiña de la cabeza. Actas Dermosifiliogr. 2008;99:91–100. https://doi.org/10.1016/S0001-7310(08)74630-1.

    Article  CAS  PubMed  Google Scholar 

  26. Amorim F, Sidta M, Beatriz C. Tinea capitis in street-children of Maputo, Mozambique. J Mycol Med. 2001;11:92–4.

    Google Scholar 

  27. Ginter-Hanselmayer G, Weger W, Ilkit M, Smolle J. Epidemiology of tinea capitis in Europe: current state and changing patterns. Mycoses. 2007;50(Suppl 2):6–13. https://doi.org/10.1111/j.1439-0507.2007.01424.x.

    Article  PubMed  Google Scholar 

  28. Romano C, Massai L, Difonzo EM. Dermatophytosis due to Trichophyton violaceum in Tuscany from 1985 to 1997. Mycoses. 2000;43:169–72. https://doi.org/10.1046/j.1439-0507.2000.00567.x.

    Article  CAS  PubMed  Google Scholar 

  29. Cuetara MS, Del Palacio A, Pereiro M, Noriega AR. Prevalence of undetected tinea capitis in a prospective school survey in Madrid: emergence of new causative fungi. Brit J Dermatol. 1998;138:658–60. https://doi.org/10.1046/j.1365-2133.1998.02181.x.

    Article  CAS  Google Scholar 

  30. Pomeranz AJ, Sabnis SS, McGrath GJ, Esterly NB. Asymptomatic carriers in the households of children with tinea capitis. Arch Pediatr Adolesc Med. 1999;153:483–6. https://doi.org/10.1001/archpedi.153.5.483.

    Article  CAS  PubMed  Google Scholar 

  31. Mayser P, Nenoff P, Reinel D, Abeck D, Brasch J, Daeschlein G, et al. S1 guidelines: tinea capitis. J German Soc Dermatol. 2019;18:161–79. https://doi.org/10.1111/ddg.14026.

    Article  Google Scholar 

  32. Klatte J, Van der Beek N, Kemperman P. 100 years of Wood’s lamp revised. JEADV. 2015;29:842–7. https://doi.org/10.1111/jdv.12860.

    Article  CAS  PubMed  Google Scholar 

  33. Waskiel-Burnat A, Rakowska A, Sikora M, Ciechanowicz P, Olszewska M, Rudnicka L. Trichoscopy of tinea capitis: a systematic review. Dermatol Ther Heidelb. 2020;10:43–52. https://doi.org/10.1007/s13555-019-00350-1.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. British Association of Dermatologists. Br J Dermatol. 2000;143:53–8. https://doi.org/10.1046/j.1365-2133.2000.03530.x.

    Article  CAS  PubMed  Google Scholar 

  35. Bonifaz A, Isa-Isa R, Araiza J, Cruz C, Hernández MA, Ponce RM. Cytobrush-culture method to diagnose tinea capitis. Mycopathologia. 2007;163:309–13. https://doi.org/10.1007/s11046-007-9019-6.

    Article  PubMed  Google Scholar 

  36. Verrier J, Monod M. Diagnosis of dermatophytosis using molecular biology. Mycopathologia. 2017;182(1–2):193–202. https://doi.org/10.1007/s11046-016-0038-z.

    Article  CAS  PubMed  Google Scholar 

  37. Sugita T, Shiraki Y, Hiruma M. Real-time PCR TaqMan assay for detecting Trichophyton tonsurans, a causative agent of tinea capitis, from hairbrushes. Med Mycol. 2006;44:579–81. https://doi.org/10.1080/13693780600717153.

    Article  CAS  PubMed  Google Scholar 

  38. Tey HL, Tan AS, Chan YC. Meta-analysis of randomized, controlled trials comparing griseofulvin and terbinafine in the treatment of tinea capitis. J Am Acad Dermatol. 2011;64:663–70. https://doi.org/10.1016/j.jaad.2010.02.048.

    Article  CAS  PubMed  Google Scholar 

  39. Gupta AK, Cooper EA, Bowen JE. Meta-analysis: griseofulvin efficacy in the treatment of tinea capitis. J Drugs Dermatol. 2008;7(4):369–72.

    PubMed  Google Scholar 

  40. Gupta AK, Drummond-Main C. Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis. Pediatr Dermatol. 2013;30:1–6. https://doi.org/10.1111/j.1525-1470.2012.01866.x.

    Article  PubMed  Google Scholar 

  41. • Bar J, Samuelov L, Sprecher E, Mashiah J. Griseofulvin vs terbinafine for paediatric tinea capitis: when and for how long. Mycoses. 2019;62:949–53. https://doi.org/10.1111/myc.12970(This article shows the efficacy of both medications).

    Article  CAS  PubMed  Google Scholar 

  42. Chen X, Jiang X, Yang M, et al. Systemic antifungal therapy for tinea capitis in children. Cochrane Database Syst Rev. 2016;5:Cd004685. https://doi.org/10.1002/14651858.CD004685.pub3.

    Article  Google Scholar 

  43. •• Chen X, Jiang X, Yang M, et al. Systemic antifungal therapy for tinea capitis in children: an abridged Cochrane Review. J Am Acad Dermatol. 2017;76(2):368–74. https://doi.org/10.1016/j.jaad.2016.08.061(This article is an update of the original review showing the efficacy of griseofulvin and terbinafine in tinea capitis in children).

    Article  PubMed  Google Scholar 

  44. Hawkins D, Smidt A. Superficial fungal infections in children. Pediatr Clin N Am. 2014;61:443–55. https://doi.org/10.1016/j.pcl.2013.12.003.

    Article  Google Scholar 

  45. Hussain I, Muzaffar F, Rashid T, Ahmad TJ, Jahangir M, Haroon TS. A randomized, comparative trial of treatment of kerion celsi with griseofulvin plus oral prednisolone vs. griseofulvin alone. Med Mycol. 1999;37:97–09.

    Article  CAS  PubMed  Google Scholar 

  46. Kelly B. Superficial fungal infections. Pediatr Rev. 2012;33:e22–37. https://doi.org/10.1542/pir.33-4-e22.

    Article  PubMed  Google Scholar 

  47. Nara Frota A, Canato M, Arake Zanatta D, et al. Majocchi granuloma on a child’s face. Dermatol Online J. 2018;24(12):13.

    Google Scholar 

  48. Soligo Kanaan IC, Kawa Kac B, Mosca de Cerqueira AM, et al. Majocchi’s granuloma- case report. Am Bras Dermatol. 2015;90(2):251–3. https://doi.org/10.1590/abd1806-4841.20153115.

    Article  Google Scholar 

  49. Wen-Wei F, Hsiu-Chao C, Hung-Chi C. Majocchi’s granuloma in a 3-year-old boy. Pediatr Infect Dis J. 2006;25:658–9. https://doi.org/10.1097/01.inf.0000224312.87417.fc.

    Article  Google Scholar 

  50. Sahoo A, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review. Indian Dermatol Online J. 2016;7(2):77–86. https://doi.org/10.4103/2229-5178.178099.

    Article  PubMed  PubMed Central  Google Scholar 

  51. El-Gohary M, van Zuuren EJ, Fedorowicz Z, Burgess H, Doney L, Stuart B, et al. Topical antifungal treatments for tinea cruris and tinea corporis. Cochrane Database Syst Rev. 2014;(8):Art. No.: CD009992. https://doi.org/10.1002/14651858.CD009992.pub2.

  52. Kaur R, Kashyap B, Makkar R. Evaluation of clinicomycological aspects of onychomycosis. Indian J Dermatol. 2008;53(4):174–8. https://doi.org/10.4103/0019-5154.44788.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Vásquez-del Mercado E, Arenas R. Onicomicosis en niños. Estudio retrospectivo de 233 casos mexicanos [Onychomycosis among children. A retrospective study of 233 Mexican cases]. Gac Med Mex. 2008;144(1):7–10.

    PubMed  Google Scholar 

  54. Bonifaz A, Saúl A, Mena C, Valencia A, Paredes V, Fierro L, et al. Dermatophyte onychomycosis in children under 2 years of age: experience of 16 cases. J Eur Acad Dermatol Venereol. 2007;21(1):115–7. https://doi.org/10.1111/j.1468-3083.2006.01802.x.

    Article  CAS  PubMed  Google Scholar 

  55. Chu DH, Rubin AI. Diagnosis and management of nail disorders in children. Pediatr Clin N Am. 2014;61(2):293–308. https://doi.org/10.1016/j.pcl.2013.11.005.

    Article  Google Scholar 

  56. Gupta AK, Mays RR, Versteeg SG, Shear NH, Friedlander SF. Onychomycosis in children: safety and efficacy of antifungal agents. Pediatr Dermatol. 2018;35(5):552–9. https://doi.org/10.1111/pde.13561.

    Article  PubMed  Google Scholar 

  57. Rodríguez-Pazos L, Pereiro-Ferreirós MM, Pereiro M Jr, Toribio J. Onychomycosis observed in children over a 20-year period. Mycoses. 2011;54(5):450–3. https://doi.org/10.1111/j.1439-0507.2010.01878.x.

    Article  PubMed  Google Scholar 

  58. Lange M, Roszkiewicz J, Szczerkowska-Dobosz A, Jasiel-Walikowska E, Bykowska B. Onychomycosis is no longer a rare finding in children. Mycoses. 2006;49(1):55–9. https://doi.org/10.1111/j.1439-0507.2005.01186.x.

    Article  CAS  PubMed  Google Scholar 

  59. Carvalho VO, Vicente VA, Werner B, et al. Onychomycosis by Fusarium oxysporum probably acquired in utero. Med Mycol Case Rep. 2014;6:58–61. Published 2014 Oct 5. https://doi.org/10.1016/j.mmcr.2014.09.005.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Peña-Penabad C, García-Silva J, Almagro M, del Pozo J, Fonseca E. Superficial white onychomycosis in a 3-year-old human immunodeficiency virus-infected child. J Eur Acad Dermatol Venereol. 2001;15(1):51–3. https://doi.org/10.1046/j.1468-3083.2001.00182.x.

    Article  PubMed  Google Scholar 

  61. García-Romero MT, Lopez-Aguilar E, Arenas R. Onychomycosis in immunosuppressed children receiving chemotherapy [published correction appears in Pediatr Dermatol. 2014 Nov-Dec;31(6):759]. Pediatr Dermatol. 2014;31(5):618–20. https://doi.org/10.1111/pde.12030.

    Article  PubMed  Google Scholar 

  62. García-Romero MT, Granados J, Vega-Memije ME, Arenas R. Analysis of genetic polymorphism of the HLA-B and HLA-DR loci in patients with dermatophytic onychomycosis and in their first-degree relatives. Actas Dermosifiliogr. 2012;103(1):59–62. https://doi.org/10.1016/j.adengl.2011.03.017.

    Article  PubMed  Google Scholar 

  63. Alvarado Z, Pereira C. Fungal diseases in children and adolescents in a referral centre in Bogota, Colombia. Mycoses. 2018;61(8):543–8. https://doi.org/10.1111/myc.12774.

    Article  CAS  PubMed  Google Scholar 

  64. Ploysangam T, Lucky AW. Childhood white superficial onychomycosis caused by Trichophyton rubrum: report of seven cases and review of the literature. J Am Acad Dermatol. 1997;36(1):29–32. https://doi.org/10.1016/s0190-9622(97)70321-9.

    Article  CAS  PubMed  Google Scholar 

  65. Moreno G, Arenas R. Other fungi causing onychomycosis. Clin Dermatol. 2010;28(2):160–3. https://doi.org/10.1016/j.clindermatol.2009.12.009.

    Article  PubMed  Google Scholar 

  66. Gupta AK, Skinner AR, Baran R. Onychomycosis in children: an overview. J Drugs Dermatol. 2003;2(1):31–4.

    PubMed  Google Scholar 

  67. Wilsmann-Theis D, Sareika F, Bieber T, Schmid-Wendtner MH, Wenzel J. New reasons for histopathological nail-clipping examination in the diagnosis of onychomycosis. J Eur Acad Dermatol Venereol. 2011;25(2):235–7. https://doi.org/10.1111/j.1468-3083.2010.03704.x.

    Article  CAS  PubMed  Google Scholar 

  68. Haghani I, Shokohi T, Hajheidari Z, Khalilian A, Aghili SR. Comparison of diagnostic methods in the evaluation of onychomycosis. Mycopathologia. 2013;175(3–4):315–21. https://doi.org/10.1007/s11046-013-9620-9.

    Article  CAS  PubMed  Google Scholar 

  69. Feldstein S, Totri C, Friedlander SF. Antifungal therapy for onychomycosis in children. Clin Dermatol. 2015;33(3):333–9. https://doi.org/10.1016/j.clindermatol.2014.12.010.

    Article  PubMed  Google Scholar 

  70. Eichenfield LF, Friedlander SF. Pediatric onychomycosis: the emerging role of topical therapy. J Drugs Dermatol. 2017;16(2):105–9.

    PubMed  Google Scholar 

  71. Friedlander SF, Chan YC, Chan YH, Eichenfield LF. Onychomycosis does not always require systemic treatment for cure: a trial using topical therapy. Pediatr Dermatol. 2013;30(3):316–22. https://doi.org/10.1111/pde.12064.

    Article  PubMed  Google Scholar 

  72. Bonifaz A, Ibarra G. Onychomycosis in children: treatment with bifonazole-urea. Pediatr Dermatol. 2000;17(4):310–4. https://doi.org/10.1046/j.1525-1470.2000.01761.x.

    Article  CAS  PubMed  Google Scholar 

  73. Patel D, Castelo-Soccio LA, Rubin AI, Streicher JL. Laboratory monitoring during systemic terbinafine therapy for pediatric Onychomycosis. JAMA Dermatol. 2017;153(12):1326–7. https://doi.org/10.1001/jamadermatol.2017.4483.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Gupta AK, Paquet M. Systemic antifungals to treat onychomycosis in children: a systematic review. Pediatr Dermatol. 2013;30(3):294–302. https://doi.org/10.1111/pde.12048.

    Article  PubMed  Google Scholar 

  75. Avner S, Nir N, Henri T. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis. J Dermatolog Treat. 2005;16(5–6):327–30. https://doi.org/10.1080/09546630500420183.

    Article  CAS  PubMed  Google Scholar 

  76. Gupta AK, Drummond-Main C, Cooper EA, Brintnell W, Piraccini BM, Tosti A. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol. 2012;66(3):494–502. https://doi.org/10.1016/j.jaad.2011.02.038.

    Article  PubMed  Google Scholar 

  77. Yamada T, Maeda M, Alshahni MM, Tanaka R, Yaguchi T, Bontems O, et al. Terbinafine resistance of Trichophyton clinical isolates caused by specific point mutations in the squalene epoxidase gene. Antimicrob Agents Chemother. 2017;61. https://doi.org/10.1128/AAC.00115-17.

  78. Hiruma J, Kitagawa H, Noguchi H, Kano R, Hiruma M, Kamata H, et al. Terbinafine-resistant strain of Trichophyton interdigitale strain isolated from a tinea pedis patient. J Dermatol. 2019;46:351–3. https://doi.org/10.1111/1346-8138.14809.

    Article  CAS  PubMed  Google Scholar 

  79. Saunte DML, Hare RK, Jørgensen KM, Jørgensen R, Deleuran M, Zachariae CO, et al. Emerging terbinafine resistance in Trichophyton: clinical characteristics, squalene epoxidase gene mutations and a reliable EUCAST method for detection. Antimicrob Agents Chemother. 2019;63:e01126-19. https://doi.org/10.1128/AAC.01126-19.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Monod M. Antifungal resistance in dermatophytes: emerging problem and challenge for the medical community. J Mycol Méd. 2019;29:283–4. https://doi.org/10.1016/j.mycmed.2019.100913.

    Article  CAS  PubMed  Google Scholar 

  81. Khurana A, Sardana K, Chowdhary A. Antifungal resistance in dermatophytes: recent trends and therapeutic implications. Fungal Genet Biol. 2019;132:103–255. https://doi.org/10.1016/j.fgb.2019.103255.

    Article  CAS  Google Scholar 

  82. Verma S, Madhu R. The great Indian epidemic of superficial dermatophytosis: an appraisal. Indian J Dermatol. 2017;62:227–36. https://doi.org/10.4103/ijd.IJD_206_17.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Friedman D, Schwartz I. Emerging fungal infections: new patients, new patterns, and new pathogens. Journal of Fungi. 2019;5:67. https://doi.org/10.3390/jof5030067.

    Article  CAS  PubMed Central  Google Scholar 

  84. Ebert A, Monod M, Salamin K, Burmester A, Uhrlaß S, Wiegand C, et al. Alarming India-wide phenomenon of antifungal resistance in dermatophytes: a multicentre study. Mycoses. 2020;63(7):717–28. https://doi.org/10.1111/myc.13091.

    Article  CAS  PubMed  Google Scholar 

  85. Kronborg Andersen L, Cavling Arendrup M, Sommerlund M. Recurrent terbinafine resistant Trichophyton rubrum infection in a child with congenital ichthyosis. Pediatr Dermatol. 2018;35:1–2. https://doi.org/10.1111/pde.13411.

    Article  Google Scholar 

  86. Gupta A, Batra R, Bluhm R, Faergemann J. Pityriasis versicolor. Dermatol Clin. 2003;21:413–29. https://doi.org/10.1016/S0733-8635(03)00039-1.

    Article  PubMed  Google Scholar 

  87. Saunte D, Gaitanis G, James-Hay R. Malassezia-associated skin diseases, the use of diagnostics and treatment. Front Cell Infect Microbiol. 2020;10:112. https://doi.org/10.3389/fcimb.2020.00112.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Terragni L, Lasagni A, Oriani A, Gelmetti C. Pityriasis versicolor in the pediatric age. Pediatr Dermatol. 1991;8(1):9–12. https://doi.org/10.1111/j.1525-1470.1991.tb00831.x.

    Article  CAS  PubMed  Google Scholar 

  89. Cullen SI. Age of patients with pityriasis versicolor. J Am Acad Dermatol. 1983;9:464–5.

    Article  CAS  PubMed  Google Scholar 

  90. Kallini J, Riaz F, Khachemoune A. Tinea versicolor in dark-skinned individuals. Int J Dermatol. 2014;53(2):137–41. https://doi.org/10.1111/ijd.12345.

    Article  PubMed  Google Scholar 

  91. Maymone M, Watchmaker J, Dubiel M, Wirya S, Shen L, Vashi N. Common skin disorders in pediatric skin of color. J Pediatr Health Care. 2019;33:727–37. https://doi.org/10.1016/j.pedhc.2019.04.019.

    Article  PubMed  Google Scholar 

  92. Mendez-Tovar L. Pathogenesis of dermatophytosis and tinea versicolor. Clin Dermatol. 2009;28(2):185–9. https://doi.org/10.1016/j.clindermatol.2009.12.015.

    Article  Google Scholar 

  93. •• Jubert E, Martín-Santiago A, Bernardino M, Bauzá A. Neonatal pityriasis versicolor. Pediatr Infect Dis J. 2015;34:329–30. https://doi.org/10.1097/INF.0000000000000568(This article details specific characteristics of pityriasis versicolor in the neonatal period).

    Article  PubMed  Google Scholar 

  94. Allegue F, Fachal C, González-Villas D, Zulaica A. Atrophying pityriasis versicolor. Act Dermosifiliogr. 2018;109(5):455–7. https://doi.org/10.1016/j.adengl.2018.04.011.

    Article  CAS  Google Scholar 

  95. •• Stephen J, Magro C. Atrophying pityriasis versicolor as an idiosyncratic T cell mediated response to Malassezia: a case series. J Am Acad Dermatol. 2017;76:730–5. https://doi.org/10.1016/j.jaad.2016.08.062(The authors describe this rare variant we must be familiar with in order to understand the underlying pathophysiology and differentiate it from other entities).

    Article  Google Scholar 

  96. • Hu S, Bigby M. Pityriasis versicolor. A systematic review of interventions. Arch Dermatol. 2010;146(10):1132–14. https://doi.org/10.1001/archdermatol.2010.259(There is a wide range of treatments for PV. (This article details the available medications, dosages, presentations, and their adverse effects).

    Article  PubMed  Google Scholar 

  97. Kaur I, Jakhar D, Singai A. Dermoscopy in the evaluation of pityriasis versicolor: a cross sectional study. Indian Dermatol Online J. 2019;10(6):682–5. https://doi.org/10.4103/idoj.IDOJ_502_18.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Pantazidou A, Tebruegge M. Recurrent tinea versicolor: treatment with itraconazole or fluconazole? Arch Dis Child. 2007;92(11):1040–2. https://doi.org/10.1136/adc.2007.124958.

    Article  PubMed  Google Scholar 

  99. •• Bakr E, Abdo H, Abd-Elaziz H, Abd-Elrazek H, Amer M. Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: a randomized clinical study. Dermatol Ther. 2020:e13319. https://doi.org/10.1111/dth.13319(This combination treatment was found to be effective to decrease scale and itch, and achieve mycological cure as well as patient satisfaction).

  100. Alberdi E, Gómez C. Successful treatment of Pityriasis Versicolor by photodynamic therapy mediated by methylene blue. Photodermatol Photoimmunol Photomed. 2020;00:1–5. https://doi.org/10.1111/phpp.12555.

    Article  CAS  Google Scholar 

  101. Mahajan VK. Sporotrichosis: an overview and therapeutic options. Dermatol Res Pract. 2014;2014:272376–13. https://doi.org/10.1155/2014/272376.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Arenas R. Sporotrichosis. In: Arenas R, Estrada R, editors. Tropical dermatology. Georgetown: Landes Bioscience; 2001.

    Chapter  Google Scholar 

  103. Lyon GM, Zurita S, Casquero J, Holgado W, Guevara J, Brandt ME, et al. Sporotrichosis in Peru Investigation Team. Population-based surveillance and a case-control study of risk factors for endemic lymphocutaneous sporotrichosis in Peru. Clin Infect Dis. 2003;36:34–9. https://doi.org/10.1086/345437 Epub 2002 Dec 12.

    Article  CAS  PubMed  Google Scholar 

  104. Ramírez Soto MC. Sporotrichosis: The story of an endemic region in Peru over 28 years (1985 to 2012). PLoS One. 2015;10(6):e0127924 Published 2015 Jun 1. https://doi.org/10.1371/journal.pone.0127924.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Ramos-e-Silva M, Vasconcelos C, Carneiro S, Cestari T. Sporotrichosis. Clin Dermatol. 2007;25:181–7. https://doi.org/10.1016/j.clindermatol.2006.05.006.

    Article  PubMed  Google Scholar 

  106. •• Bonifaz A, Saúl A, Paredes-Solis V, Fierro L, Rosales A, Palacios C, et al. Sporotrichosis in childhood: clinical and therapeutic experience in 25 patients. Pediatr Dermatol. 2007;24(4):369–72. https://doi.org/10.1111/j.1525-1470.2007.00452.x(This paper shows clearly the clinical spectrum for sporotrichosis in children).

    Article  PubMed  Google Scholar 

  107. McGuinness SL, Boyd R, Kidd S, McLeod C, Krause VL, Ralph AP. Epidemiological investigation of an outbreak of cutaneous sporotrichosis, Northern Territory. Australia BMC Infect Dis. 2016;16(1):16. https://doi.org/10.1186/s12879-016-1338-0 PMID: 26758905.

    Article  CAS  PubMed  Google Scholar 

  108. Pappas PG, Tellez I, Deep AE, Nolasco D, Holgado W, Bustamante B. Sporotrichosis in Peru: description of an area of hyperendemicity. Clin Infect Dis. 2000;30(1):65–70. https://doi.org/10.1086/313607.

    Article  CAS  PubMed  Google Scholar 

  109. da Rosa AC, Scroferneker ML, Vettorato R, Gervini RL, Vettorato G, Weber A. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol. 2005;52(3 Pt 1):451–9. https://doi.org/10.1016/j.jaad.2004.11.046.

    Article  PubMed  Google Scholar 

  110. •• Tirado-Sánchez A, Bonifaz A. Sporotrichosis in children: an update. Curr Fungal Infect Rep. 2016;10:107–16. https://doi.org/10.1007/s12281-016-0259-0(This article is an excellent review of sporotrichosis in children).

    Article  Google Scholar 

  111. Sanchotene KO, Madrid IM, Klafke GB, Bergamashi M, Della Terra PP, Rodrigues AM, et al. Sporothrix brasiliensis outbreaks and the rapid emergence of feline sporotrichosis. Mycoses. 2015;58(11):652–8. PMID: 26404561. https://doi.org/10.1111/myc.12414.

    Article  PubMed  Google Scholar 

  112. Gremião ID, Menezes RC, Schubach TM, Figueiredo AB, Cavalcanti MC, Pereira SA. Feline sporotrichosis: epidemiological and clinical aspects. Med Mycol. 2015;53(1):15–21. https://doi.org/10.1093/mmy/myu061 Epub 2014 Dec 4.

    Article  CAS  PubMed  Google Scholar 

  113. Barros MB, Costa DL, Schubach TM, do Valle AC, Lorenzi NP, Teixeira JL, et al. Endemic of zoonotic sporotrichosis: profile of cases in children. Pediatr Infect Dis J. 2008;27(3):246–50. https://doi.org/10.1097/INF.0b013e31815bf309.

    Article  PubMed  Google Scholar 

  114. Orofino-Costa R, Macedo PM, Rodrigues AM, Bernardes-Engemann AR. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. An Bras Dermatol. 2017;92(5):606–20. https://doi.org/10.1590/abd1806-4841.2017279.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Takenaka M, Yoshizaki A, Utani A, Nishimoto K. A survey of 165 sporotrichosis cases examined in Nagasaki prefecture from 1951 to 2012. Mycoses. 2014;57(5):294–8. https://doi.org/10.1111/myc.12158 Epub 2013 Nov 28.

    Article  PubMed  Google Scholar 

  116. Verma S, Verma GK, Singh G, Kanga A, Shanker V, Singh D, et al. Sporotrichosis in sub-Himalayan India. PLoS Negl Trop Dis. 2012;6(6):e1673. https://doi.org/10.1371/journal.pntd.0001673 Epub 2012 Jun 12.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Rippon JW. Sporotrichosis. In: Rippon JW, editor. Medical mycology: the pathogenic fungi and the pathogenic actinomycetes. Philadelphia: WB Saunders; 1988. p. 325–52.

    Google Scholar 

  118. Morris-Jones R. Sporotrichosis. Clin Exp Dermatol. 2002;27:427–31. https://doi.org/10.1046/j.1365-2230.2002.01087.x.

    Article  CAS  PubMed  Google Scholar 

  119. Kauffman CA, Bustamante B, Chapman SW, Pappas PG, Infectious Diseases Society of America. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45(10):1255–65. https://doi.org/10.1086/522765.

    Article  CAS  PubMed  Google Scholar 

  120. Yamada K, Zaitz C, Framil VM, Muramatu LH. Cutaneous sporotrichosis treatment with potassium iodide: a 24 year experience in São Paulo State, Brazil. Rev Inst Med Trop Sao Paulo. 2011;53(2):89–93. https://doi.org/10.1590/s0036-46652011000200006.

    Article  PubMed  Google Scholar 

  121. Vásquez-del-Mercado E, Arenas R, Padilla-Desgarenes C. Sporotrichosis. Clin Dermatol. 2012;30(4):437–43. https://doi.org/10.1016/j.clindermatol.2011.09.017.

    Article  PubMed  Google Scholar 

  122. •• Brito AC, Bittencourt MJS. Chromoblastomycosis: an etiological, epidemiological, clinical, diagnostic, and treatment update. An Bras Dermatol. 2018;93(4):495–506. https://doi.org/10.1590/abd1806-4841.20187321(The article provides an update of epidemiological, clinical, diagnostic, and therapeutic features.).

    Article  PubMed  PubMed Central  Google Scholar 

  123. McGinnis MR. Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology. J Am Acad Dermatol. 1983;8(1):1–16. https://doi.org/10.1016/s0190-9622(83)70001-0.

    Article  CAS  PubMed  Google Scholar 

  124. Rubin HA, Bruce S, Rosen T, McBride ME. Evidence for percutaneous inoculation as the mode of transmission for chromoblastomycosis. J Am Acad Dermatol. 1991;25(5 Pt 2):951–4. https://doi.org/10.1016/0190-9622(91)70292-a.

    Article  CAS  PubMed  Google Scholar 

  125. Arenas R. Chromoblastomycosis. In: Arenas R, Estrada R, editors. Tropical dermatology. Georgetown, TX: Landes Bioscience; 2001.

    Chapter  Google Scholar 

  126. Krzyściak PM, Pindycka-Piaszczyńska M, Piaszczyński M. Chromoblastomycosis. Postepy Dermatol Alergol. 2014;31(5):310–21. https://doi.org/10.5114/pdia.2014.40949.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Naka W, Harada T, Nishikawa T, Fukushiro R. A case of chromoblastomycosis: with special reference to the mycology of the isolated Exophiala jeanselmei. Mykosen. 1986;29(10):445–52. https://doi.org/10.1111/j.1439-0507.1986.tb03943.x.

    Article  CAS  PubMed  Google Scholar 

  128. Barba-Gómez JF, Mayorga J, McGinnis MR, González-Mendoza A. Chromoblastomycosis caused by Exophiala spinifera. J Am Acad Dermatol. 1992;26(2 Pt 2):367–70. https://doi.org/10.1016/0190-9622(92)70058-n.

    Article  PubMed  Google Scholar 

  129. Padhye AA, Hampton AA, Hampton MT, Hutton NW, Prevost-Smith E, Davis MS. Chromoblastomycosis caused by Exophiala spinifera. Clin Infect Dis. 1996;22(2):331–5. https://doi.org/10.1093/clinids/22.2.331.

    Article  CAS  PubMed  Google Scholar 

  130. Tomson N, Abdullah A, Maheshwari MB. Chromomycosis caused by Exophiala spinifera. Clin Exp Dermatol. 2006;31(2):239–41. https://doi.org/10.1111/j.1365-2230.2005.02006.x.

    Article  CAS  PubMed  Google Scholar 

  131. • Pérez-Blanco M, Hernández Valles R, García-Humbría L, Yegres F. Chromoblastomycosis in children and adolescents in the endemic area of the Falcón State, Venezuela. Med Mycol. 2006;44(5):467–71. https://doi.org/10.1080/13693780500543238(This article shows the importance of early diagnosis and intervention in children with chromoblastomycosis).

    Article  PubMed  Google Scholar 

  132. Agarwal R, Singh G, Ghosh A, Verma KK, Pandey M, Xess I. Chromoblastomycosis in India: review of 169 cases. PLoS Negl Trop Dis. 2017;11(8):e0005534. Published 2017 Aug 3. https://doi.org/10.1371/journal.pntd.0005534.

    Article  PubMed  PubMed Central  Google Scholar 

  133. •• Queiroz-Telles F, de Hoog S, Santos DW, et al. Chromoblastomycosis. Clin Microbiol Rev. 2017;30(1):233–76. https://doi.org/10.1128/CMR.00032-16(This article is an excellent review of chromoblastomycosis).

    Article  CAS  PubMed  Google Scholar 

  134. Navarrete MR, Arenas R, Estrada VFM, Diéguez CEA, Mayorga J, Bonifaz A, et al. Cromoblastomicosis en México. Revisión de 603 casos en siete décadas. Dermatologia CMQ. 2014;12:87–93.

    Google Scholar 

  135. Tsuneto LT, Arce-Gomez B, Petzl-Erler ML, Queiroz-Telles F. HLA-A29 and genetic susceptibility to chromoblastomycosis. J Med Vet Mycol. 1989;27(3):181–5. https://doi.org/10.1080/02681218980000241.

    Article  CAS  PubMed  Google Scholar 

  136. Pradeepkumar NS, Joseph NM. Chromoblastomycosis caused by Cladophialophora carrionii in a child from India. J Infect Dev Ctries. 2011;5(7):556–60. Published 2011 Jul 27. https://doi.org/10.3855/jidc.1392.

    Article  PubMed  Google Scholar 

  137. Bonifaz A, Carrasco-Gerard E, Saúl A. Chromoblastomycosis: clinical and mycologic experience of 51 cases. Mycoses. 2001;44(1–2):1–7. https://doi.org/10.1046/j.1439-0507.2001.00613.x.

    Article  CAS  PubMed  Google Scholar 

  138. Londero AT, Ramos CD. Chromomycosis: a clinical and mycologic study of thirty-five cases observed in the hinterland of Rio Grande do Sul, Brazil. Am J Trop Med Hyg. 1976;25(1):132–5. https://doi.org/10.4269/ajtmh.1976.25.132.

    Article  CAS  PubMed  Google Scholar 

  139. Lupi O, Tyring SK, McGinnis MR. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol. 2005;53(6):931–54. https://doi.org/10.1016/j.jaad.2004.10.883.

    Article  PubMed  Google Scholar 

  140. Esterre P, Andriantsimahavandy A, Ramarcel ER, Pecarrere JL. Forty years of chromoblastomycosis in Madagascar: a review. Am J Trop Med Hyg. 1996;55(1):45–7. https://doi.org/10.4269/ajtmh.1996.55.45.

    Article  CAS  PubMed  Google Scholar 

  141. Esterre P, Andriantsimahavandy A, Raharisolo C. Histoire naturelle des chromoblastomycoses à Madagascar et dans l’Océan indien [natural history of chromoblastomycosis in Madagascar and the Indian Ocean] natural history of chromoblastomycosis in Madagascar and the [natural history of chromoblastomycosis in Madagascar and the Indian Ocean]. Bull Soc Pathol Exot. 1997;90(5):312–7.

    CAS  PubMed  Google Scholar 

  142. Iwatsu T, Takano M, Okamoto S. Auricular chromomycosis. Arch Dermatol. 1983;119(1):88–9.

    Article  CAS  PubMed  Google Scholar 

  143. Takase T, Baba T, Uyeno K. Chromomycosis. A case with a widespread rash, lymph node metastasis and multiple subcutaneous nodules. Mycoses. 1988;31(7):343–52. https://doi.org/10.1111/j.1439-0507.1988.tb04429.x.

    Article  CAS  PubMed  Google Scholar 

  144. Azulay RD, Serruya J. Hematogenous dissemination in chromoblastomycosis. Report of a generalized case. Arch Dermatol. 1967;95(1):57–60.

    Article  CAS  PubMed  Google Scholar 

  145. Gopal KVT, Ramani TV, Panda S, Laxmi PVBR. Disseminated chromoblastomycosis: diffuse truncal involvement with hematogenous spread. Int J Health Allied Sci. 2012;1(3):194±6. https://doi.org/10.4103/2278-344X.105087.

    Article  Google Scholar 

  146. Torres E, Beristain JG, Lievanos Z, Arenas R. Chromoblastomycosis associated with a lethal squamous cell carcinoma. An Bras Dermatol. 2010;85(2):267–70. https://doi.org/10.1590/s0365-05962010000200025.

    Article  PubMed  Google Scholar 

  147. Sharma N, Marfatia YS. Genital elephantiasis as a complication of chromoblastomycosis: a diagnosis overlooked. Indian J Sex Transm Dis AIDS. 2009;30(1):43–5. https://doi.org/10.4103/0253-7184.55486.

    Article  PubMed  PubMed Central  Google Scholar 

  148. Caplan RM. Epidermoid carcinoma arising in extensive chromoblastomycosis. Arch Dermatol. 1968;97(1):38–41.

    Article  CAS  PubMed  Google Scholar 

  149. Foster HM, Harris TJ. Malignant change (squamous carcinoma) in chronic chromoblastomycosis. Aust N Z J Surg. 1987;57(10):775–7. https://doi.org/10.1111/j.1445-2197.1987.tb01260.x.

    Article  CAS  PubMed  Google Scholar 

  150. Oberto-Perdigón L, Romero H, Pérez-Blanco M, Apitz-Castro R. Inmunoanálisis enzimático (ELISA) en la evolución terapéutica de la cromoblastomicosis por Cladophialophora carrionii en el área endémica del Estado Falcón, Venezuela [an ELISA test for the study of the therapeutic evolution of chromoblastomycosis by Cladophialophora carrionii in the endemic area of Falcon State, Venezuela]. Rev Iberoam Micol. 2005;22(1):39–43. https://doi.org/10.1016/s1130-1406(05)70005-x.

    Article  PubMed  Google Scholar 

  151. Tsianakas A, Pappai D, Basoglu Y, Metze D, Tietz HJ, Luger TA, et al. Chromomycosis--successful CO2 laser vaporization. J Eur Acad Dermatol Venereol. 2008;22(11):1385–6. https://doi.org/10.1111/j.1468-3083.2008.02649.x.

    Article  CAS  PubMed  Google Scholar 

  152. Hira K, Yamada H, Takahashi Y, Ogawa H. Successful treatment of chromomycosis using carbon dioxide laser associated with topical heat applications. J Eur Acad Dermatol Venereol. 2002;16(3):273–5. https://doi.org/10.1046/j.1468-3083.2002.00479.x.

    Article  CAS  PubMed  Google Scholar 

  153. Lyon JP, Pedroso e Silva Azevedo C de M, Moreira LM, de Lima CJ, de Resende MA. Photodynamic antifungal therapy against chromoblastomycosis. Mycopathologia. 2011;172(4):293–7. https://doi.org/10.1007/s11046-011-9434-6.

    Article  CAS  PubMed  Google Scholar 

  154. Yang Y, Hu Y, Zhang J, Li X, Lu C, Liang Y, et al. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy. Med Mycol. 2012;50(6):649–53. https://doi.org/10.3109/13693786.2012.655258.

    Article  CAS  PubMed  Google Scholar 

  155. Queiroz-Telles F, Purim KS, Fillus JN, et al. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol. 1992;31(11):805–12. https://doi.org/10.1111/j.1365-4362.1992.tb04252.x.

    Article  CAS  PubMed  Google Scholar 

  156. Restrepo A, Gonzalez A, Gomez I, Arango M, de Bedout C. Treatment of chromoblastomycosis with itraconazole. Ann N Y Acad Sci. 1988;544:504–16. https://doi.org/10.1111/j.1749-6632.1988.tb40448.x.

    Article  CAS  PubMed  Google Scholar 

  157. Bonifaz A, Saúl A, Paredes-Solis V, Araiza J, Fierro-Arias L. Treatment of chromoblastomycosis with terbinafine: experience with four cases. J Dermatolog Treat. 2005;16(1):47–51. https://doi.org/10.1080/09546630410024538.

    Article  CAS  PubMed  Google Scholar 

  158. Tanuma H, Hiramatsu M, Mukai H, Abe M, Kume H, Nishiyama S, et al. Case report. A case of chromoblastomycosis effectively treated with terbinafine. Characteristics of chromoblastomycosis in the Kitasato region, Japan. Mycoses. 2000;43(1–2):79–83. https://doi.org/10.1046/j.1439-0507.2000.00548.x.

    Article  CAS  PubMed  Google Scholar 

  159. Esterre P, Inzan CK, Ramarcel ER, et al. Treatment of chromomycosis with terbinafine: preliminary results of an open pilot study. Br J Dermatol. 1996;134(Suppl 46):33–40. https://doi.org/10.1111/j.1365-2133.1996.tb15658.x.

    Article  PubMed  Google Scholar 

  160. Azevedo Cde M, Marques SG, Resende MA, et al. The use of glucan as immunostimulant in the treatment of a severe case of chromoblastomycosis. Mycoses. 2008;51(4):341–4. https://doi.org/10.1111/j.1439-0507.2007.01485.x.

    Article  CAS  PubMed  Google Scholar 

  161. de Sousa MG, Belda W Jr, Spina R, et al. Topical application of imiquimod as a treatment for chromoblastomycosis. Clin Infect Dis. 2014;58(12):1734–7. https://doi.org/10.1093/cid/ciu168.

    Article  CAS  PubMed Central  Google Scholar 

  162. •• Zijlstra EE, van de Sande WWJ, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH. Mycetoma: a unique neglected tropical disease. Lancet Infect Dis. 2016;16(1):100–12. https://doi.org/10.1016/S1473-3099(15)00359-X(This article is an excellent review of the topic).

    Article  PubMed  Google Scholar 

  163. Fahal AH. Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg. 2004;98(1):3–11. https://doi.org/10.1016/s0035-9203(03)00009-9.

    Article  CAS  PubMed  Google Scholar 

  164. Fahal AH, Sabaa AH. Mycetoma in children in Sudan. Trans R Soc Trop Med Hyg. 2010;104(2):117–21. https://doi.org/10.1016/j.trstmh.2009.07.016.

    Article  CAS  PubMed  Google Scholar 

  165. Bonifaz A, Ibarra G, Saúl A, Paredes-Solis V, Carrasco-Gerard E, Fierro-Arias L. Mycetoma in children: experience with 15 cases. Pediatr Infect Dis J. 2007;26(1):50–2. https://doi.org/10.1097/01.inf.0000247108.86199.64.

    Article  PubMed  Google Scholar 

  166. Welsh O. Mycetoma in children. Mod Probl Paediatr. 1975;17:248–53.

    CAS  PubMed  Google Scholar 

  167. Pulikot AM, Bapat SS, Tolat S. Mycetoma of the sole. Ann Trop Paediatr. 2002;22(2):187–90. https://doi.org/10.1179/027249302125000931.

    Article  PubMed  Google Scholar 

  168. Tovar-Garza AP, Barrientos-García JG, Mayorga J. Micetoma en pacientes pediátricos. Reporte de 19 casos. Dermatol Rev Mex. 2015;59:189–94.

    Google Scholar 

  169. Maiti PK, Ray A, Bandyopadhyay S. Epidemiological aspects of mycetoma from a retrospective study of 264 cases in West Bengal. Tropical Med Int Health. 2002;7(9):788–92. https://doi.org/10.1046/j.1365-3156.2002.00915.x.

    Article  CAS  Google Scholar 

  170. Buot G, Lavalle P, Mariat F, Suchil P. Etude épidémiologique des mycétomes au Mexique. A propos de 502 cas [Epidemiologic study of mycetomas in Mexico. Apropos of 502 cases]. Bull Soc Pathol Exot Filiales. 1987;80(3):329–39.

    CAS  PubMed  Google Scholar 

  171. Khatri ML, Al-Halali HM, Fouad Khalid M, Saif SA, Vyas MC. Mycetoma in Yemen: clinicoepidemiologic and histopathologic study. Int J Dermatol. 2002;41(9):586–93. https://doi.org/10.1046/j.1365-4362.2002.01383.x.

    Article  PubMed  Google Scholar 

  172. Kwizera R, Bongomin F, Meya DB, Denning DW, Fahal AH, Lukande R. Mycetoma in Uganda: a neglected tropical disease. PLoS Negl Trop Dis. 2020;14(4):e0008240. Published 2020 Apr 29. https://doi.org/10.1371/journal.pntd.0008240.

    Article  PubMed  PubMed Central  Google Scholar 

  173. Hernandez-Hernandez F, Lopez-Martinez R, Mendez-Tovar LJ, Manzano-Gayosso P. Nocardia brasiliensis: in vitro and in vivo growth response to steroid sex hormones. Mycopathologia. 1995;132(2):79–85. https://doi.org/10.1007/BF01103779.

    Article  CAS  PubMed  Google Scholar 

  174. Emmanuel P, Dumre SP, John S, Karbwang J, Hirayama K. Mycetoma: a clinical dilemma in resource limited settings. Ann Clin Microbiol Antimicrob. 2018;17(1):35. Published 2018 Aug 10. https://doi.org/10.1186/s12941-018-0287-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  175. Welsh O, Vera-Cabrera L, Salinas-Carmona MC. Mycetoma. Clin Dermatol. 2007;25(2):195–202. https://doi.org/10.1016/j.clindermatol.2006.05.011.

    Article  PubMed  Google Scholar 

  176. Dieng MT, Niang SO, Diop B, Ndiaye B. Actinomycétomes au Sénégal. Etude de 90 cas [Actinomycetomas in Senegal: study of 90 cases]. Bull Soc Pathol Exot. 2005;98(1):18–20.

    CAS  PubMed  Google Scholar 

  177. Estrada R, Chávez-López G, Estrada-Chávez G, López-Martínez R, Welsh O. Eumycetoma. Clin Dermatol. 2012;30(4):389–96. https://doi.org/10.1016/j.clindermatol.2011.09.009.

    Article  PubMed  Google Scholar 

  178. Ameen M, Arenas R. Developments in the management of mycetomas. Clin Exp Dermatol. 2009;34(1):1–7. https://doi.org/10.1111/j.1365-2230.2008.03028.x.

    Article  CAS  PubMed  Google Scholar 

  179. Bonifaz A, Tirado-Sánchez A, Calderón L, et al. Mycetoma: experience of 482 cases in a single center in Mexico. PLoS Negl Trop Dis. 2014;8(8):e3102. Published 2014 Aug 21. https://doi.org/10.1371/journal.pntd.0003102.

    Article  PubMed  PubMed Central  Google Scholar 

  180. Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis. 2004;4(9):566–74. https://doi.org/10.1016/S1473-3099(04)01131-4.

    Article  PubMed  Google Scholar 

  181. Fahal AH. Mycetoma. In: Guerrant RL, Walker DH, Weller PF, editors. Tropical infectious diseases. Principles, Pathogens and Practice. 3rd ed. Amsterdam: Elsevier; 2011. p. 565–568.

  182. López Martínez R, Méndez Tovar LJ, Lavalle P, Welsh O, Saúl A, Macotela RE. Epidemiología del micetoma en México: estudio de 2105 casos [Epidemiology of mycetoma in Mexico: study of 2105 cases]. Gac Med Mex. 1992;128(4):477–81.

    PubMed  Google Scholar 

  183. Fahal A, Suleiman S, Hay R. Mycetoma: the spectrum of clinical presentation. Tropical Medicine and Infectious Disease. 2018;3:97. https://doi.org/10.3390/tropicalmed3030097.

    Article  PubMed Central  Google Scholar 

  184. Bonifaz A, González-Silva A, Albrandt-Salmerón A, Padilla Mdel C, Saúl A, Ponce RM. Utility of helical computed tomography to evaluate the invasion of actinomycetoma; a report of 21 cases. Br J Dermatol. 2008;158(4):698–704. https://doi.org/10.1111/j.1365-2133.2008.08435.x.

    Article  CAS  PubMed  Google Scholar 

  185. Lichon V, Khachemoune A. Mycetoma : a review. Am J Clin Dermatol. 2006;7(5):315–21. https://doi.org/10.2165/00128071-200607050-00005.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, National Institute of Pediatrics, Mexico City, Mexico

    Maria Teresa García-Romero & Silvia Angélica Carmona-Cruz

  2. American British Cowdray Medical Center, Mexico City, Mexico

    Gabriela Sánchez-Cardenas

  3. Department of Dermatology, National Institute of Respiratory Diseases, Calz. de Tlalpan 4502, Belisario Domínguez Secc 16, Tlalpan, 14080, Mexico City, Mexico

    Mónica Fernández-Sánchez

Authors
  1. Maria Teresa García-Romero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gabriela Sánchez-Cardenas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Silvia Angélica Carmona-Cruz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mónica Fernández-Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mónica Fernández-Sánchez.

Ethics declarations

Conflict of Interest

Maria Teresa García-Romero, Gabriela Sánchez-Cardenas, Silvia Angélica Carmona-Cruz, and Mónica Fernández Sánchez declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Pediatric Fungal Infections

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

García-Romero, M.T., Sánchez-Cardenas, G., Carmona-Cruz, S.A. et al. Skin Fungal Infections in Children: Diagnostic Challenges. Curr Fungal Infect Rep 14, 329–347 (2020). https://doi.org/10.1007/s12281-020-00407-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12281-020-00407-1

Keywords

Search

Navigation